Clinical trials
Recruiting Phase 1 Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
65 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 14 |
| 2025 | 21 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 65 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| West China Hospital | 3 |
| Lion TCR Pte. Ltd. | 2 |
| M.D. Anderson Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Second Affiliated Hospital of Guangzhou Medical University | 2 |
| AbbVie | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
| Alnylam Pharmaceuticals | 1 |
| Aptamer Sciences, Inc. | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 65 |
| Carcinoma, Non-Small-Cell Lung | 14 |
| Colorectal Neoplasms | 10 |
| Liver Neoplasms | 10 |
| Carcinoma, Renal Cell | 9 |
| Melanoma | 8 |
| Endometrial Neoplasms | 7 |
| Ovarian Neoplasms | 7 |
| Pancreatic Neoplasms | 7 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
Trials
Showing 1 to 25 of 65. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.